Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 62
Filtrar
3.
Vet Rec ; 195(6): 258, 2024 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-39485200

RESUMO

Krishna Prasad Acharya and Sarita Phuyal argue that while low- to middle-income countries may have some rabies control initiatives in place, these are not fully effective and strategies must be improved to reach the global goal of eliminating human deaths from dog-transmitted rabies by 2030.


Assuntos
Países em Desenvolvimento , Doenças do Cão , Raiva , Raiva/prevenção & controle , Raiva/veterinária , Raiva/epidemiologia , Animais , Humanos , Cães , Doenças do Cão/prevenção & controle , Doenças do Cão/epidemiologia , Doenças do Cão/virologia , Vacina Antirrábica/administração & dosagem
4.
Vet Rec ; 195(6): 254-255, 2024 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-39485226
7.
Asian J Psychiatr ; 101: 104209, 2024 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-39241651

RESUMO

BACKGROUND: Despite the widespread use of attention-deficit hyperactivity disorder (ADHD) medications and their known sympathomimetic effects on the cardiovascular system, cardiovascular risk assessment of these medications using comprehensive global data is limited. This study investigated the association between individual ADHD medications and cardiovascular disease (CVD) using global pharmacovigilance data. METHODS: Reports from the World Health Organization international pharmacovigilance database were utilized (1967-2023; total reports, n=131,255,418). Reporting odds ratios (ROR), and information components (IC) were calculated to evaluate the association between each medication and specific CVDs. RESULTS: We identified 13,344 CVD cases related to ADHD medications out of 146,489 cases of all reports on ADHD medications. Cumulative reports on ADHD medications have shown a steady increase, notably in adults since 2010. ADHD medications were associated with a higher risk of CVD overall (ROR [95 % CI], 1.60 [1.58-1.63]; IC [IC0.25], 0.63 [0.60]), with a higher association observed in females than in males. Among specific CVDs, all drugs were associated with an increased risk of torsade de pointes/QT prolongation, cardiomyopathy, and myocardial infarction. Conversely, heart failure, stroke, and cardiac death/shock were exclusively associated with amphetamines. Lisdexamfetamine showed a weaker association with all CVDs compared to amphetamines, and methylphenidate exhibited the lowest overall association with CVD. Atomoxetine had the second-highest association with torsade de pointes/QT prolongation. CONCLUSIONS: The associations between CVDs and ADHD medications vary, with amphetamines posing a higher risk, while lisdexamfetamine and methylphenidate exhibit better safety profiles.


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade , Doenças Cardiovasculares , Estimulantes do Sistema Nervoso Central , Bases de Dados Factuais , Farmacovigilância , Organização Mundial da Saúde , Humanos , Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Transtorno do Deficit de Atenção com Hiperatividade/epidemiologia , Masculino , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/induzido quimicamente , Feminino , Adulto , Pessoa de Meia-Idade , Adulto Jovem , Adolescente , Estimulantes do Sistema Nervoso Central/efeitos adversos , Criança , Pré-Escolar , Idoso , Saúde Global/estatística & dados numéricos , Lactente
11.
Infect Dis Poverty ; 13(1): 28, 2024 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-38610035

RESUMO

BACKGROUND: Despite the increasing focus on strengthening One Health capacity building on global level, challenges remain in devising and implementing real-world interventions particularly in the Asia-Pacific region. Recognizing these gaps, the One Health Action Commission (OHAC) was established as an academic community for One Health action with an emphasis on research agenda setting to identify actions for highest impact. MAIN TEXT: This viewpoint describes the agenda of, and motivation for, the recently formed OHAC. Recognizing the urgent need for evidence to support the formulation of necessary action plans, OHAC advocates the adoption of both bottom-up and top-down approaches to identify the current gaps in combating zoonoses, antimicrobial resistance, addressing food safety, and to enhance capacity building for context-sensitive One Health implementation. CONCLUSIONS: By promoting broader engagement and connection of multidisciplinary stakeholders, OHAC envisions a collaborative global platform for the generation of innovative One Health knowledge, distilled practical experience and actionable policy advice, guided by strong ethical principles of One Health.


Assuntos
Saúde Única , Animais , Ásia , Fortalecimento Institucional , Políticas , Zoonoses/prevenção & controle
16.
Nat Commun ; 14(1): 5819, 2023 09 20.
Artigo em Inglês | MEDLINE | ID: mdl-37730734

RESUMO

Benefits of breastfeeding for both the mother and the child are well established, but a comprehensive and robust study to investigate the protective effect of breastfeeding and attenuated time effect stratified by cause of morbidity are lacking. This study is based on the nationwide birth cohort in Korea that includes data on all infants born from 2009 to 2015. Of 1,608,540 children, the median follow-up period was 8.41 years (interquartile range, 6.76-10.06). When compared to children with fully formula feeding, the hospital admission rate was 12% lower in those with partially breastfeeding and 15% lower in those with exclusive breastfeeding. The apparent protective effect of breastfeeding was reduced with increasing age. Our study provides potential evidence of the beneficial association of breastfeeding on subsequent hospital admissions. The protective effect declined over time as the children grew older. Encouraging any breastfeeding for at least the first 6 months among infants is an important public health strategy to improve overall child health.


Assuntos
Coorte de Nascimento , Aleitamento Materno , Criança , Lactente , Feminino , Humanos , República da Coreia/epidemiologia , Saúde da Criança , Hospitais
17.
Trans R Soc Trop Med Hyg ; 117(6): 435-443, 2023 06 02.
Artigo em Inglês | MEDLINE | ID: mdl-36611273

RESUMO

BACKGROUND: Snakebite is a neglected public health issue in Nepal. We aimed to characterize patients with snake envenoming admitted to hospital in south-western Nepal. METHODS: This was a prospective cohort study of 476 snakebite patients admitted to Bheri Hospital from May to December 2017. Data were collected on patient demographics, bite circumstances, snake type, treatment-seeking behavior, clinical effects, complications and treatment. RESULTS: There were 139/476 (29%) patients with clinical features of envenomation and 10 deaths (8%), of which six were prehospital deaths; 325/476 (68%) patients used non-recommended prehospital first aid, including 278 (58%) who applied a tourniquet and 43 (9%) consulting traditional healers. Median time to hospital arrival was 1.5 (IQR: 0.8-4) h. Also, 127 envenomated patients (91%) developed neurotoxicity and 12 (9%) hemotoxicity, while 124 patients (89%) received antivenom, with a median dose of 10 (4-30) vials. Three patients developed anaphylaxis following antivenom administration; 111 of 139 (80%) cases were admitted to the ICU and 48 (35%) were intubated. Median length of hospital stay for all cases was 0.5 (IQR: 0.5-1.2) d, but it was 2.2 (IQR: 1.5-3.8) d for envenomated cases. CONCLUSIONS: The majority of snakebite patients used non-recommended first aid or attended traditional healers. Almost one-third of patients developed systemic envenomation and required antivenom. The case fatality rate was high, but many died prior to arriving in hospital.


Assuntos
Mordeduras de Serpentes , Humanos , Animais , Mordeduras de Serpentes/complicações , Mordeduras de Serpentes/epidemiologia , Mordeduras de Serpentes/terapia , Antivenenos/uso terapêutico , Estudos Prospectivos , Nepal/epidemiologia , Centros de Atenção Terciária , Venenos de Serpentes , Serpentes
18.
Infect Dis Rep ; 14(6): 979-986, 2022 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-36547243

RESUMO

In many third world countries, where rabies is endemic in dog populations, humans continue to be at risk of contracting the disease. Vaccination is the most effective form of prophylaxis for people, yet it often fails to adequately protect dogs. The most major implications are the costs of post-exposure prophylaxis (PEP) after an exposure occurs and the loss of human life and productivity due to early mortality from rabies (about 60,000 deaths annually). The largest rabies death tolls can be found in the world's poorest regions, where rabies vaccinations for domestic dogs are uncommon and PEP is scarce. Mass vaccination of dogs, neutering programs, patient PEP, strengthening laboratory and human resources, education and awareness, and animal and human rabies surveillance are all common methods used to prevent, control, and ultimately eradicate dog-mediated human rabies. Current rabies control initiatives, however, pay little attention to the role that ecological and socioeconomic variables play in the disease's occurrence and spread. To help better inform rabies control strategies, we address in this work the ways in which ecological and socioeconomic factors affect the occurrence and spread of rabies.

19.
J Trop Med ; 2022: 5942693, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36211623

RESUMO

Rabies is a vaccine-preventable fatal viral disease that is zoonotic in nature. In this article, we provide a justification why the agreement of the World Health Organization (WHO), the Food and Agriculture Organization (FAO), the World Organization for Animal Health (OIE), and Global Alliance for Rabies Control (GARC) on The Global Strategic Plan to End Human Deaths from Dog-mediated Rabies by 2030 should also include a more holistic approach and ecologic views.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...